Skip to main content
鹿得医疗 logo

鹿得医疗 — Investor Relations & Filings

Ticker · 920278 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2022-08-28 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920278

About 鹿得医疗

https://www.asian-medical.com/

Jiangsu Lude Medical Device Co., Ltd. specializes in the research, development, and manufacturing of home medical diagnostic and respiratory care equipment. The company's core product portfolio includes mechanical and electronic sphygmomanometers, stethoscopes, nebulizers, and digital thermometers. It focuses on providing high-precision instruments for chronic disease management and home healthcare. With a strong emphasis on technical innovation and quality control, the firm maintains various international quality certifications to support its global OEM and ODM service capabilities. Its products are designed to meet the needs of both professional medical environments and domestic health monitoring, emphasizing accuracy, reliability, and user-friendly operation in the field of physiological parameter measurement.

Recent filings

Filing Released Lang Actions
第三届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, attendance, and the approval of several proposals including the 2022 semi-annual report, a special report on the use of raised funds, and the appointment of an audit firm for 2022. The document references the actual semi-annual report and other reports being disclosed elsewhere (on the Beijing Stock Exchange website) with specific announcement numbers. The document itself does not contain the financial data or the full report but is a formal announcement of the meeting decisions and approvals. Given the short length (1484 characters) and the nature of the content (meeting resolutions and approvals), this fits best under Regulatory Filings (RNS) as it is a regulatory announcement of meeting resolutions rather than the report itself or a detailed management or audit report.
2022-08-28 Chinese
第三届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 13th meeting of the 3rd Board of Directors of Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, attendance, agenda items, and voting results. The document references other reports such as the 2022 semi-annual report and a special report on the use of raised funds, but it does not contain the reports themselves. Instead, it states that these reports are disclosed elsewhere (on the Beijing Stock Exchange website) and provides announcement numbers. The document is relatively short (2020 characters) and serves as an official announcement of board meeting decisions rather than the reports or financial data themselves. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2022-08-28 Chinese
拟续聘会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (立信会计师事务所) as the auditor for the company's 2022 annual audit. It includes details about the accounting firm, its qualifications, past records, and the board's approval of the proposal. There is no actual audit report or financial statements included, nor is there detailed financial analysis. The document is a formal announcement about the auditor appointment process and related procedures, not the audit report itself. Therefore, it fits best under Audit Report / Information (AR) category, which covers standalone audit reports and related audit information excluding full annual reports. The document length is under 5,000 characters and it is not merely a report publication announcement or certification letter, so AR is appropriate. FY 2022
2022-08-28 Chinese
关于更换持续督导保荐代表人的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the change of the continuous supervision sponsor representative for a company listed on the Beijing Stock Exchange. It details the replacement of a sponsor representative due to personal reasons and provides the new representative's resume. There is no financial data, report, or detailed analysis present. The document is a regulatory announcement about management changes related to sponsorship and supervision roles, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Board/Management Information (MANG) which typically involves changes in the company's board or senior management, not sponsor representatives.
2022-07-31 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding a share repurchase program by the company 江苏鹿得医疗电子股份有限公司. It details the repurchase plan, including the number of shares to be repurchased, price limits, purpose, and the progress made up to a certain date. The document does not contain financial statements or comprehensive financial analysis but focuses on the update of the share buyback activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2022-07-31 Chinese
购买资产的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the purchase of assets, specifically the acquisition of a 30% equity stake in a subsidiary company. It details the transaction overview, parties involved, pricing, and the impact on the company. The document explicitly states that the transaction does not constitute a major asset restructuring and does not require board or shareholder approval. There are no financial statements or detailed financial performance data included. The document is a formal announcement of a corporate transaction rather than a full financial report or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as asset purchases or equity acquisitions.
2022-07-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.